Knight’s $500 Million Gift
Druker has been talking about this approach to diagnostics for at least a decade.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
